NAP is about investigating all natural medicines with real world impact. Pharmacognosy is the study of medicinal drugs derived from plants and other natural sources, focusing on their biochemical properties and therapeutic potential. This blog explores the traditional uses and biochemistry of Kratom and Kava, highlighting their roles in herbal medicine and the need for scientific research to better understand their effects.

In a previous blog post, we explored the available scientific information on cannabigerol (CBG) and anxiety from three different peer-reviewed sources. The findings suggested that CBG is effective for anxiety, but there was a need for more information, because the effect was only slightly above placebo and at specific time points. In partnership with MoreBetter, NAP presents a rapid report into the first individual-specific onset data for CBG taken in real-time and a proof of concept for future studies.

This two-year, first-of-its-kind research initiative will combine laboratory research with consumer feedback to analyze cultivation and processing metrics to determine the factors that contribute to the most pleasant and least harmful smoking experience.

The Science Behind Smokeability

July 10th or 7/10 is the day to celebrate concentrates, because 7/10 is “OIL” upside down. Concentrates are a large and ever-expanding class of cannabis products that can be used in many ways but are typically dabbed or vaped. Read on to see the most popular dabbing “dosage” from our early analysis!

The first intentional LSD experience by Dr. Albert Hoffmann was on April 19th and there’s no need to introduce 4/20 to this community. At MJUnpacked, NAP collected data at our booth on the top research priorities of the community and the results highlight the need for accelerated research on the lived experience of cannabis consumers.

On March 23 and 24th, NAP was at NECANN Boston collecting data and launching the “Weird Brains” science advocacy panel tour. Research will play a critical role in destigmatizing cannabis and advocating for increased access. Involving the community in the data collection process opens the doors for research to remain tangible and relevant to the cannabis community.

The stigmatization of cannabis and the negative stereotyping of the cannabis community comes from a history of propaganda, including the intentional devaluation of medical cannabis use. Some of our initial analysis highlights the need for more research that focuses on the benefits. Introducing the “Stoner Neurotype” - a perspective shift in how we view higher needs medical cannabis patients, or daily consumers, to be more neurodiversity-affirming.